1647 GMT - EssilorLuxottica's first-quarter sales proved in line with market expectations, analysts at Bernstein say in a note. The Franco-Italian eyecare titan booked an 11% organic increase in sales on year over the first three months, matching a consensus of estimates compiled by Visible Alpha. Sales grew at a similar pace in the group's retail and professional divisions, and across geographies. Bernstein has a market-perform rating on the company and a 185-euro target price on its stock. Shares closed down 2.5% at 201.50 euros.(joshua.kirby@wsj.com; @joshualeokirby)
(END) Dow Jones Newswires
April 22, 2026 12:47 ET (16:47 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.
At the request of the copyright holder, you need to log in to view this content
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments